By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Omeros Corporation 

1420 Fifth Avenue
Suite 2675
Seattle  Washington  98101  U.S.A.
Phone: 206-623-4688 Fax: 206-264-7856


SEARCH JOBS


Industry
Biotechnology






Company News
FDA Calls Omeros (OMER)' Kidney Disorder Drug a Breakthrough 6/13/2017 10:38:28 AM
Omeros (OMER) Announces OMS721 Presentation At 54th ERA-EDTA Congress 6/1/2017 8:28:50 AM
Omeros (OMER) Announces Completion Of IgA Nephropathy Cohort In OMS721 Phase II Clinical Trial 5/17/2017 7:20:29 AM
Omeros (OMER) To Announce First Quarter 2017 Financial Results On May 10, 2017 5/4/2017 7:12:28 AM
Omeros (OMER) To Present At The Needham Healthcare Conference 4/3/2017 1:01:49 PM
Omeros (OMER) Reports More Positive Data In OMS721 Phase II Trial In Renal Diseases 3/30/2017 7:02:44 AM
Omeros (OMER) Announces OMS721 Presentation At Annual Meeting Of The European Society For Blood And Marrow Transplantation 3/28/2017 7:42:58 AM
Omeros (OMER) To Present Results From Dose-Ranging Stage Of OMS721 Clinical Trial In Atypical Hemolytic Uremic Syndrome At World Congress Of Nephrology 3/27/2017 7:51:38 AM
Omeros (OMER) Reports Fourth Quarter And Year-End 2016 Financial Results 3/17/2017 6:31:45 AM
Omeros (OMER) To Announce Fourth Quarter And Year-End 2016 Financial Results On March 16, 2017 3/10/2017 6:30:40 AM
12345678910...
//-->